You are what you eat: O-linked N-acetylglucosamine in disease, development and epigenetics

Curr Opin Clin Nutr Metab Care. 2015 Jul;18(4):339-45. doi: 10.1097/MCO.0000000000000188.

Abstract

Purpose of review: The O-linked N-acetylglucosamine (O-GlcNAc) modification is both responsive to nutrient availability and capable of altering intracellular cellular signalling. We summarize data defining a role for O-GlcNAcylation in metabolic homeostasis and epigenetic regulation of development in the intrauterine environment.

Recent findings: O-GlcNAc transferase (OGT) catalyzes nutrient-driven O-GlcNAc addition and is subject to random X-inactivation. OGT plays key roles in growth factor signalling, stem cell biology, epigenetics and possibly imprinting. The O-GlcNAcase, which removes O-GlcNAc, is subject to tight regulation by higher order chromatin structure. O-GlcNAc cycling plays an important role in the intrauterine environment wherein OGT expression is an important biomarker of placental stress.

Summary: Regulation of O-GlcNAc cycling by X-inactivation, epigenetic regulation and nutrient-driven processes makes it an ideal candidate for a nutrient-dependent epigenetic regulator of human disease. In addition, O-GlcNAc cycling influences chromatin modifiers critical to the regulation and timing of normal development including the polycomb repression complex and the ten-eleven translocation proteins mediating DNA methyl cytosine demethylation. The pathway also impacts the hypothalamic-pituitary-adrenal axis critical to intrauterine programming influencing disease susceptibility in later life.

Publication types

  • Research Support, N.I.H., Intramural
  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Acetylglucosamine / administration & dosage*
  • Acetylglucosamine / adverse effects*
  • Alzheimer Disease / etiology
  • Alzheimer Disease / genetics
  • Cardiovascular Diseases / etiology
  • Cardiovascular Diseases / genetics
  • Chromatin / genetics
  • Chromatin / metabolism
  • Chronic Disease
  • Diabetes Mellitus, Type 2 / etiology
  • Diabetes Mellitus, Type 2 / genetics
  • Diet
  • Epigenesis, Genetic*
  • Feeding Behavior*
  • Female
  • Gene Expression Regulation
  • Genetic Loci
  • Genomic Imprinting
  • Homeostasis / drug effects
  • Humans
  • Hypothalamo-Hypophyseal System / metabolism
  • Lupus Erythematosus, Systemic / etiology
  • Lupus Erythematosus, Systemic / genetics
  • N-Acetylglucosaminyltransferases / genetics
  • N-Acetylglucosaminyltransferases / metabolism
  • Neoplasms / etiology
  • Neoplasms / genetics
  • Neurogenesis / drug effects
  • Obesity / etiology
  • Obesity / genetics
  • Protein Processing, Post-Translational
  • X Chromosome Inactivation / physiology

Substances

  • Chromatin
  • N-Acetylglucosaminyltransferases
  • O-GlcNAc transferase
  • UDP-N-acetylglucosamine-peptide beta-N-acetylglucosaminyltransferase
  • Acetylglucosamine